Nasdaq DCF Points to 24% Overvaluation; DeepValue WAIT Rating Holds

What happened

A June 17 DCF analysis by GuruFocus estimates Nasdaq's intrinsic value at $68 per share, well below the $89 market price and even beneath the $72 bear case in DeepValue's master report. The DeepValue report maintains a WAIT rating with an attractive entry at $80, highlighting that at $87 the stock prices in durable recurring growth with limited room for disappointment. While Nasdaq's 1Q26 showed strong Solutions growth (ARR +13% YoY) and robust capital returns, the DCF underscores the risk that market expectations already embed sustained mid-teens growth and successful execution of 23/5 trading and tokenization milestones. The DCF aligns with DeepValue's bear scenario where Market Services normalizes and Solutions decelerates, but the WAIT rating reflects potential catalysts like DTCC tokenization trades in July 2026 and the December 2026 23/5 go-live. For now, the stock offers limited margin of safety; patience until key milestones and earnings confirm sustained organic bookings and ARR growth is warranted.

Implication

The DCF analysis highlights that Nasdaq's current valuation leaves no room for execution missteps. Investors should monitor the next two quarters for organic bookings growth (especially EMEA recovery) and progress on DTCC's tokenization trades and the 23/5 trading launch. If these catalysts materialize, the platform narrative could drive the stock toward the $92 base case; if they flop, downside to the $68 DCF or even the $72 bear case is plausible. The WAIT rating appropriately balances these asymmetric outcomes—capital preservation favors waiting for either a cheaper entry or confirmation of the growth thesis.

Thesis delta

The thesis remains unchanged: Nasdaq is a high-quality recurring-revenue platform but priced for perfection. The DCF analysis serves as a quantitative reminder that at $89, the stock is pricing in optimistic assumptions. The delta is nil; the WAIT stance is reinforced, with no trigger to move to BUY or SELL until next earnings and milestone updates.